"
Team:Tufts
From 2014.igem.org
(Difference between revisions)
| Line 80: | Line 80: | ||
awarded the grant and the only team in the United States. | awarded the grant and the only team in the United States. | ||
| + | In fulfillment of this grant, we are pursuing two avenues. The first is the writing of “application | ||
| + | |||
| + | scenarios” and “techno-moral scenarios” meant to discuss the feasibility and desirability of applications | ||
| + | |||
| + | of our iGEM projects. The second is the organization and hosting of a one day conference on | ||
| + | |||
| + | bacteriophage. | ||
| + | |||
| + | |||
| + | |||
| + | The conference, titled The Future of Phage and Synthetic Biology, incorporates two events. The first a | ||
| + | |||
| + | professional workshop that brings together leaders of industry, regulation, and research to discuss and | ||
| + | |||
| + | advance a pre-written framework on the intersection of bacteriophage application and associated safety | ||
| + | |||
| + | and regulation considerations. This will be followed by a public forum to present and discuss the results | ||
| + | |||
| + | with a broader audience. | ||
| + | |||
| + | |||
| + | |||
| + | In conjunction with this, we will are seeking insight into public perception and acceptance of synthetic | ||
| + | |||
| + | biology, bacteriophage, and antibiotic resistance by means of a survey. The survey will be disseminated | ||
| + | |||
| + | orally by Penn Schoen Berland (PSB) Research and online through Tufts Qualtrics. | ||
</td> | </td> | ||
<td width="35px"></td> | <td width="35px"></td> | ||
Revision as of 18:15, 15 August 2014
Tufts iGEM 2014 |
||||||||||||
| ||||||||||||
| This year, we are competing in the International Genetically Engineered Machine (iGEM) Competition with a project which uses a bacteriophage to block the formation of biofilms. We have received a grant from the European Commission’s SYNENERGENE Project which aims to initiate and foster public dialogue on synthetic biology and mutual learning processes among a wide variety of stakeholders from science, industry, civil society, education, art and other fields. We are one of eight teams to have been awarded the grant and the only team in the United States. In fulfillment of this grant, we are pursuing two avenues. The first is the writing of “application scenarios” and “techno-moral scenarios” meant to discuss the feasibility and desirability of applications of our iGEM projects. The second is the organization and hosting of a one day conference on bacteriophage. The conference, titled The Future of Phage and Synthetic Biology, incorporates two events. The first a professional workshop that brings together leaders of industry, regulation, and research to discuss and advance a pre-written framework on the intersection of bacteriophage application and associated safety and regulation considerations. This will be followed by a public forum to present and discuss the results with a broader audience. In conjunction with this, we will are seeking insight into public perception and acceptance of synthetic biology, bacteriophage, and antibiotic resistance by means of a survey. The survey will be disseminated orally by Penn Schoen Berland (PSB) Research and online through Tufts Qualtrics. | ||||||||||||
